Study: New Blood Test Can Track Alzheimer's Progression
IT Home, November 18 news — according to Reuters, the brain field has seen two new studies: one found that a new blood test could help clinicians more accurately determine the extent of Alzheimer's disease progression; the other revealed how some brain functions change with age.

New Blood Test Can Track Alzheimer's Progression
Researchers reported at the Alzheimer's Association International Conference on Clinical Trials in Boston that a new blood test can help determine how far Alzheimer's disease has progressed in the brain.
The test, developed by Alamar Biosciences, primarily measures a biomarker called eMTBR-tau. This indicator reflects the accumulation of tangled tau protein tangles in brain cells.
Existing Alzheimer's blood tests mainly measure indicators such as β-amyloid and phosphorylated tau protein. These substances rise in the early stages of the disease, but for the specific accumulation of tau tangles after the disease enters later stages, existing tests can only provide limited information.
Currently, two Alzheimer's drugs are on the market, mainly working by reducing β-amyloid plaques in the brain. Meanwhile, several drugs targeting tau protein are in development.
The study's lead researcher, Dr. Niklas Mattsson-Carlgren of Lund University in Sweden, said in a statement: "One of the most challenging tasks in Alzheimer's diagnosis is determining whether a patient with cognitive impairment not only has Alzheimer's-related pathological changes, but also whether the disease has progressed at the biological level to a stage severe enough to reasonably explain their clinical symptoms."
The researchers noted that this new blood test is not yet in clinical use and cannot be used alone to diagnose Alzheimer's disease. The related research report has been published in the Journal of the American Medical Association (JAMA).
Co-lead researcher 尼古拉斯 阿什顿 (Nicholas Ashton) of Banner Sun Health Research Institute in Sun City, Arizona, said: "Now, we hope to determine the accumulation of tau tangles in the brain through a simple method that is easy to scale up. This is an important advance in our further understanding of Alzheimer's disease."
阿什顿 said that combining existing blood tests with this new test targeting eMTBR-tau could help doctors develop more reasonable treatment plans while more accurately screening patients suitable for clinical trials.
As We Age, the Brain's Self-Cleaning Function May Weaken
Another new study found that the physiological process responsible for clearing metabolic waste from the brain during sleep is often affected in older people. Researchers hope to further explore whether this change increases the risk of neurodegenerative diseases.
During deep non-rapid eye movement sleep, electrical activity in the brain forms slow brain wave fluctuations that aid physical recovery and memory consolidation. These slow waves can be monitored by electroencephalography and are also an important factor driving cerebrospinal fluid fluctuations, and the flow of cerebrospinal fluid helps clear metabolic waste from the brain.
Researchers conducted late-night experiments on two groups of volunteers, one aged 18 to 39 and the other aged 60 to 84. Using magnetic resonance imaging (MRI) technology, they measured blood flow and cerebrospinal fluid flow in the brain, while using electroencephalography (EEG) to monitor brain waves.
IT Home noted that the related research results were published in the journal Nature Aging.
The study found that after young adults entered non-rapid eye movement sleep, the slow waves generated by brain electrical activity strengthened, and subsequently cerebrospinal fluid flow also strengthened. But in older volunteers, this phenomenon was not common.
To understand why aging leads to weakened cerebrospinal fluid flow, the researchers also conducted further experiments while subjects were fully awake.
First, the researchers had subjects complete a task that typically increases brain activity levels and blood volume, while measuring changes in brain blood flow.
The results found that many older subjects did indeed show enhanced brain neural activity, but blood flow did not increase significantly. This suggests that with age, blood vessels' ability to respond to increased oxygen demand in the brain may have weakened.
The researchers then asked subjects to hold their breath. Normally, this causes carbon dioxide levels in the blood to rise, further increasing blood flow to the brain.
But the experiment found that the average increase in cerebral blood flow in older participants was significantly lower than in younger participants.
The researchers pointed out that these two factors can explain most of the weakening of cerebrospinal fluid flow, but not all of the changes. This means there may be other aging-related factors causing reduced cerebrospinal fluid flow.
Previous studies have found that sleep disorders are associated with an increased risk of neurodegenerative diseases such as Alzheimer's disease and other dementias.
None of the subjects in this study had been diagnosed with such diseases. However, some older participants already showed signs of gray matter atrophy, and this change was correlated with a greater decline in cerebrospinal fluid flow capacity.
The researchers hope to continue long-term follow-up of some participants to further understand whether changes in cerebrospinal fluid flow are associated with an increased risk of future neurodegenerative diseases.
The study's lead researcher, Laura Lewis of the Massachusetts Institute of Technology (MIT) in the United States, said: "Some people can age very healthily and maintain good cognitive abilities throughout, while others experience cognitive decline."
Lewis noted that among some older participants in this study, their cerebrospinal fluid flow levels remained within the normal range for healthy young people.
She said: "We very much want to figure out what exactly distinguishes these people from others, and how this difference might affect their future health."